Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q2- Text added to 2019 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
alternative, Amgen, antagonist, bempegaldesleukin, Breakthrough, bring, Cardiology, care, committee, compliance, complied, concomitantly, CVR, Director, doublet, ESCC, imposed, irrevocably, lapse, maintenance, merit, moved, NaN, negotiated, nonvalvular, OAC, OS, proceed, profile, raw, regimen, SAS, smaller, sooner, successful, therefrom, trend, unconditional
Removed:
anticoagulant, constructing, Corporation, dollar, Incyte, misappropriation, newer, prejudice, private, sued, ultimate, vigorously
Valuein 2019 Q2 filing- Value in 2019 Q3 filing
Original filings
Filing view